Literature DB >> 12662288

Transmission of hepatitis A via WBC-reduced RBCs and FFP from a single donation.

A Hafeez Diwan1, James R Stubbs, Gary E Carnahan.   

Abstract

BACKGROUND: Currently, individuals donating whole blood and cellular components are not screened for hepatitis A (HA). However, transfusion-transmitted HA can occur, albeit very rarely. Although infection is typically mild and self-limited, it may be catastrophic in a small percentage of cases. Two cases of HA transmission from a single donation to two patients with subsequent variable morbidity are reported. CASE REPORTS: A 50-year-old, asymptomatic, volunteer blood donor made a whole-blood donation. He was found to have HA 18 days later. When notified, the donor center initiated a recall of the components produced from the donated unit. However, the RBCs and FFP had already been transfused. Subsequently, both recipients developed HA as documented by IgM anti-HA serology. The RBC recipient was a 49-year-old woman, transfused after a hysterectomy, who was found to have HA at the time of unit recall (20 days after transfusion). Her condition required the use of medical disability leave. The FFP was infused to a 52-year-old female cardiac surgical patient. Her course was marked by multiple complications, including postoperative development of mild hepatic dysfunction. After testing negative for HA, hepatitis B, and hepatitis C (24 days after transfusion), she suffered a second bout of more severe hepatic dysfunction and was documented to have HA at Day 55 after transfusion. Evaluation of both recipients' close contacts revealed no evidence for exposure to HA by any route other than transfusion.
CONCLUSION: HA can be transmitted by transfusion of units obtained from asymptomatic, infectious donors. Two patients contracted HA from components obtained from a single whole-blood donation. The RBC recipient had a typical self-limited course of HA. The FFP recipient developed HA of relatively delayed onset. Both recovered from HA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662288     DOI: 10.1046/j.1537-2995.2003.00342.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  6 in total

1.  Phylogenetic analysis of a transfusion-transmitted hepatitis A outbreak.

Authors:  Andrea Hettmann; Gabriella Juhász; Ágnes Dencs; Bálint Tresó; Erzsébet Rusvai; Éva Barabás; Mária Takács
Journal:  Virus Genes       Date:  2016-09-23       Impact factor: 2.332

2.  Hepatitis A: an epidemiological survey in blood donors, France 2015 to 2017.

Authors:  Pierre Gallian; Valérie Barlet; Lina Mouna; Sylvie Gross; Sophie Lecam; Céline Ricard; Françoise Wind; Elodie Pouchol; Cécile Fabra; Benoit Flan; Catherine Visse; Rachid Djoudi; Elisabeth Couturier; Henriette de Valk; Pierre Tiberghien; Anne-Marie Roque-Afonso
Journal:  Euro Surveill       Date:  2018-05

Review 3.  [Emergent viral threats in blood transfusion].

Authors:  B Pozzetto; O Garraud
Journal:  Transfus Clin Biol       Date:  2011-03-16       Impact factor: 1.406

Review 4.  Transfusion-transmitted infections.

Authors:  Florian Bihl; Damiano Castelli; Francesco Marincola; Roger Y Dodd; Christian Brander
Journal:  J Transl Med       Date:  2007-06-06       Impact factor: 5.531

5.  Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012.

Authors:  Viktor Dahl; Ammar Majeed; Agneta Wikman; Rut Norda; Gustaf Edgren
Journal:  Euro Surveill       Date:  2020-07

Review 6.  Emerging infections in transfusion medicine.

Authors:  Eberhard W Fiebig; Michael P Busch
Journal:  Clin Lab Med       Date:  2004-09       Impact factor: 1.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.